Eli Lilly And Co (NYSE:LLY) and Incyte Corporation (NASDAQ:INCY) said adolescent patients with severe alopecia areata (AA) ...
Bempikibart demonstrated positive, durable responses among patients with severe to very severe alopecia areata, according to ...
Of the states that do provide coverage for JAK inhibitors used to treat patients with alopecia, researchers found that prior ...
Thirty-six weeks of once-daily, oral baricitinib was associated with greater hair regrowth on the scalp, eyebrows and ...
Brittany Craiglow, MD, FAAD, analyzed the promising use of baricitinib for severe pediatric alopecia areata. She highlighted late-breaking data from the BRAVE-AA-PEDS study (NCT05723198), emphasizing ...
Hair loss isn’t as rare as many believe it to be, and it’s not reserved solely for the elderly. You can start experiencing it ...
Late-breaking results from Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) found adolescent patients (ages 12 to ...
'Androgenetic alopeci is the most common reason for balding in men and it's driven by the hormone dihydrotestosterone (DHT),' ...
Researchers in China have developed a specialized patch test for hair care products to identify allergens in patients ...
Hair fall is a nightmare no one wants to experience. Whether it's finding strands of hair on the pillow or watching them clog ...